3m Innovative Properties Company

Archer Daniels Midland Company

Robert T Fitzsimons, Jr

Jerald K Rasmussen

Kannan Seshadri

James I Hembre

Catherine A Bothof

George W Griesgraber

Simon Kelly Shannon

Peter D Wickert

Yi He

Masayuki Nakamura

Erin A Satterwhite

Babu Nana Gaddam

Duane Douglas Fansler

Todd D Jones

Louis C Haddad

Semra Colak Atan

Andrew W Rabins

Jie Jerry Liu

Mahfuza B Ali

Amy K McNulty

Douglas A Hanggi

Minghua Dai

Jana Ninkovic

Federica Sgolastra

Larry J Carson

Kelly J Gibbens

Kevin Michael Lewandowski

Steven M Heilmann

Michael S Wendland

Wayne Scott Mahoney

John J Cael

James L Hembre

Kurt J Halverson

David R Holm

Charles Abbas

Graham M Clarke

John F Reed

Dan L Fanselow

Kiu-Yuen Tse

Wei Zhang

Del R Lawson

Matt Dyer

Bryan A Baker

Taib K Ansera

Jerod Fults

Stephen M Larsen

Dan L Brown

Mark D Isder

Travis Nelson

Brian Bone

Rhea J Sammons

Jerry Barnes

An article, including a network of interconnected polymeric strands; wherein each of the interconnected polymeric strands has a first surface adapted to contact a tissue site and a second surface opposite the first surface; wherein at least one of the interconnected polymeric stand has a plurality of features extending from the first surface of the interconnected polymeric strands; wherein at least one of the interconnected polymeric strands is non-linear; a plurality of openings between adjacent interconnected polymeric strands; an adhesive layer in contact with the second surface of the interconnected polymeric strands; and a filler in contact with the adhesive layer, the adhesive layer in between the network of interconnected polymeric strands and the filler; wherein the article is a negative pressure wound therapy article.

Negative pressure wound therapy article with features

A substrate comprising a crosslinked polymer primer layer, and grafted thereto a ligand-functionalized polymer is provided. The grafted polymer has the requisite affinity for binding neutral or negatively charged biomaterials, such as cells, cell debris, bacteria, spores, viruses, nucleic acids, and proteins, at pH's near or below the pI's of the biomaterials.

Ligand functional substrates

A polypeptide having a sequence at least 60% identical to SEQ ID NO: 1 (WFEWPYWEMNVPDVWN) is provided. The polypeptide includes no more than 100 total amino acid residues.

Peptides for binding epidermal growth factor

An article that can be used for biomaterial capture comprises

Ligand-functionalized substrates with enhanced binding capacity

A polypeptide having a sequence at least 70% identical to SEQ ID NO: 1 (YVSPGMKNVNWWSHWWHATD) is provided. The polypeptide includes no more than 100 total amino acid residues.

The present invention is directed to a system and method for producing an organic compound using fermentation wherein multiple components of the system are recycled within the system. The system and method allow for extraction of a high concentration of the organic compound from the fermentation broth in a continuous system that allows recycling of the biomass, aqueous fermentation broth and extraction solvents. The system and method are particularly well adapted for producing and extracting ethanol.

System and method for extracting ethanol from a fermentation broth

Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.

Ligand functionalized polymers

Guanidine-functionalized particles and methods of making and using such particles.

Guanidine-functionalized particles and methods of making and using

An article that can be used for biomaterial capture comprises (a) a porous substrate; and (b) borne on the porous substrate, a polymer comprising interpolymerized units of at least one monomer consisting of (1) at least one monovalent ethylenically unsaturated group, (2) at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof, and (3) a multivalent spacer group that is directly bonded to the monovalent groups so as to link at least one ethylenically unsaturated group and at least one ligand functional group by a chain of at least six catenated atoms.

Ligand functionalized substrates with enhanced binding capacity

Growing community of inventors

Minneapolis, MN, United States of America

Robert T Fitzsimons, Jr